Hyperactive Delirium Clinical Trial
Official title:
A Pilot Study of an Interactive Digital Technology (MindfulGarden) in Treatment of Hyperactive Delirium in a Hospital Setting
This pilot study is designed to address feasibility for a larger randomized control clinical study that will determine the efficacy of exposure to the MindfulGarden - an interactive digital technology - in reducing hyperactive delirium in hospitalized older adults.
The primary objective of the study is to establish whether the key components necessary for
conducting a full randomized control study in the future, such as recruitment, consent,
randomization, and treatment processes are working well and all function together. As a
secondary objective, the investigators will determine trends in patients exposed to
MindfulGarden (MG), for example:
1. At the first and second administration of the Confusion Assessment Method - short form
(CAM) after admission to a medical ward are there more, the same or fewer patients in
the intervention group than in the control group whose CAM scores change from positive
to negative?
2. During the first 24 hours after admission to a medical ward, did fewer, the same, or a
greater number of patients in the intervention than in the control group experience
significant events/alerts (e.g. aggressive/violent behaviours, falls, code white)?
3. During the first 24 hours after admission to a medical ward, were fewer, the same, or a
greater number of patients in the intervention than in the control group administered
psychotropic drugs (e.g. haloperidol, risperidone, quetiapine, lorazepam)? were more,
the same, or fewer administered sleeping aids (e.g. trazodone, melatonin)?
4. During the first 24 hours after admission to a medical ward, were fewer, the same, or a
greater number of patients in the intervention than in the control group physically
restrained?
5. Was mean length of stay from time of admission to a medical ward until discharge due to
death, return to place of residence before admission or to a different place of
residence longer, the same or shorter in the intervention than in the control group?
6. Were there more, the same or fewer deaths or discharges to a higher level of care (e.g.
to assisted living, to a complex care facility in patients who previously lived at home)
in the intervention than the control group?
Additionally, to the extent that movement and vocalization are reflective of anxiety,
agitation and/or aggression (i.e. responsive behaviours) the investigators also want to
determine whether there is a correlation between changes in these as recorded by the MG and
any of the indicators listed in 1-6 above.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03215745 -
Delirium Prevention in Patients From the Intensive Care Unit (DELA)
|
N/A | |
| Recruiting |
NCT04824144 -
Effects of Dexmedetomidine in Patients With Agitated Delirium in Palliative Care
|
Phase 1/Phase 2 | |
| Recruiting |
NCT04833023 -
HALO Trial: Haloperidol vs Olanzapine in Hyperactive Delirium in Palliative Care Patients; A Multi-Centre, Randomised-Controlled Trial
|
Phase 3 | |
| Withdrawn |
NCT04513314 -
Valproate Alone or in Combination With Quetiapine for Severe COVID-19 Pneumonia With Agitated Delirium
|
Phase 4 | |
| Terminated |
NCT02343575 -
Valproic Acid for Treatment of Hyperactive or Mixed Delirium in ICU
|
Phase 4 | |
| Completed |
NCT03954769 -
A Pilot Study of "Stanford Proxy Test for Delirium" (S-PTD)
|
||
| Completed |
NCT05690698 -
Quetiapine Versus Haloperidol in the Management of Hyperactive Delirium
|
Phase 3 |